Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Amyloid efflux mediated by p-glycoprotein.

F C Lam1, R Liu, P Lu

  • 1Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada.

Journal of Neurochemistry
|February 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement.

Eye (London, England)·2015
Same author

Sterile keratitis after combined riboflavin-UVA corneal collagen cross-linking for keratoconus.

Eye (London, England)·2014
Same author

Establishment of reference panel for human platelet antigen genotyping.

Vox sanguinis·2014
Same author

Partial least squares based gene expression analysis in estrogen receptor positive and negative breast tumors.

European review for medical and pharmacological sciences·2014
Same author

Monitoring progress toward measles elimination by genetic diversity analysis of measles viruses in China 2009-2010.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
Same author

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity.

Leukemia·2013

P-glycoprotein (p-gp) acts as an efflux pump, actively transporting beta-amyloid (Abeta) out of cells. Blocking p-gp reduces Abeta secretion, offering a new target for Alzheimer's disease (AD) therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is linked to increased brain beta-amyloid (Abeta) burden.
  • Intracellular Abeta production is understood, but its cellular secretion mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of p-glycoprotein (p-gp) in the cellular secretion of Abeta.
  • To identify novel mechanisms for Abeta detachment from cell membranes.

Main Methods:

  • Utilized in vitro binding studies with synthetic Abeta peptides and p-gp enriched vesicles.
  • Measured Abeta peptide transport across plasma membranes in an ATP- and p-gp-dependent manner.
  • Investigated the effect of pharmacological blockade of p-gp on extracellular Abeta levels.

Related Experiment Videos

Main Results:

  • Identified p-glycoprotein (p-gp), an ABC transporter, as an Abeta efflux pump.
  • Demonstrated direct interaction between synthetic Abeta1-40/Abeta1-42 peptides and p-gp.
  • Showed that p-gp blockade significantly reduces extracellular Abeta secretion.
  • Confirmed ATP- and p-gp-dependent transport of Abeta peptides.

Conclusions:

  • p-gp mediates the efflux of Abeta peptides from cells, representing a novel secretion mechanism.
  • This finding provides a potential therapeutic target for reducing Abeta accumulation in Alzheimer's disease.
  • Further research into brain Abeta efflux mechanisms is warranted.